Clinical Biomarkers and World CDx Summit Boston

Memo

The 9th Clinical Biomarkers and World CDx Boston 2018 summit is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.



As the place to be for the precision medicine field, Clinical Biomarkers and World CDx Boston covers end-to-end the development, clinical implementation and commercialisation of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from RandD to providing patients with the right treatment decision and most effective therapies at the right time.



http://world-cdx.com/



Contact:

This email address is being protected from spambots. You need JavaScript enabled to view it.

+44 (0)20 3141 8700



URLs:

Brochure: https://go.evvnt.com/233980-0?pid=5569

Tickets: https://go.evvnt.com/233980-1?pid=5569



Time: 8:00 am to 4:00 pm



Prices:

Drug Developer Conference Earlybird (Book by 15/06/18): USD 1499.0,

Drug Developer Conference (Standard rate): USD 2399.0,

Service Provider Conference Earlybird (Book by 15/06/18): USD 2199.0,

Service Provider Conference (Standard rate): USD 3099.0



Speakers: Majid Ghoddusi (Juno Therapeutics), Soma Ray (Vertex Pharmaceuticals), Joshua Bilenker (Loxo Oncology), Eric Yang (GSK), Roy Beveridge (Humana), Emmanuelle di Tomaso (Syros Pharmaceuticals), Jennifer Hall (American Heart Association), Robert Loberg (Amgen), Julianna Lisziewicz (Treos Bio)



Venue Details: Renaissance Boston Waterfront, 606 Congress Street, Boston, 02210, United States